Cargando…
Degeneration of retinal ganglion cells in hypoxic responses: hypoxia-inducible factor inhibition, a new therapeutic insight
Autores principales: | Lee, Deokho, Kunimi, Hiromitsu, Negishi, Kazuno, Kurihara, Toshihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083171/ https://www.ncbi.nlm.nih.gov/pubmed/35259842 http://dx.doi.org/10.4103/1673-5374.335801 |
Ejemplares similares
-
Pemafibrate, a potent selective peroxisome proliferator-activated receptor α modulator, a promising novel treatment for ischemic retinopathy?
por: Lee, Deokho, et al.
Publicado: (2022) -
Retinal Diseases Regulated by Hypoxia—Basic and Clinical Perspectives: A Comprehensive Review
por: Shinojima, Ari, et al.
Publicado: (2021) -
Retinal Degeneration in a Murine Model of Retinal Ischemia by Unilateral Common Carotid Artery Occlusion
por: Lee, Deokho, et al.
Publicado: (2021) -
Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration
por: Lee, Deokho, et al.
Publicado: (2023) -
Starburst amacrine cells amplify optogenetic visual restoration through gap junctions
por: Katada, Yusaku, et al.
Publicado: (2023)